2026年一本密卷高考英语
注:目前有些书本章节名称可能整理的还不是很完善,但都是按照顺序排列的,请同学们按照顺序仔细查找。练习册 2026年一本密卷高考英语 答案主要是用来给同学们做完题方便对答案用的,请勿直接抄袭。
第25页
- 第1页
- 第2页
- 第3页
- 第4页
- 第5页
- 第6页
- 第7页
- 第8页
- 第9页
- 第10页
- 第11页
- 第12页
- 第13页
- 第14页
- 第15页
- 第16页
- 第17页
- 第18页
- 第19页
- 第20页
- 第21页
- 第22页
- 第23页
- 第24页
- 第25页
- 第26页
- 第27页
- 第28页
- 第29页
- 第30页
- 第31页
- 第32页
- 第33页
- 第34页
- 第35页
- 第36页
- 第37页
- 第38页
- 第39页
- 第40页
- 第41页
- 第42页
- 第43页
- 第44页
- 第45页
- 第46页
- 第47页
- 第48页
- 第49页
- 第50页
- 第51页
- 第52页
- 第53页
- 第54页
- 第55页
- 第56页
- 第57页
- 第58页
- 第59页
- 第60页
- 第61页
- 第62页
- 第63页
- 第64页
- 第65页
- 第66页
- 第67页
- 第68页
- 第69页
- 第70页
- 第71页
- 第72页
- 第73页
- 第74页
- 第75页
- 第76页
- 第77页
- 第78页
- 第79页
- 第80页
- 第81页
- 第82页
- 第83页
- 第84页
- 第85页
- 第86页
- 第87页
- 第88页
- 第89页
- 第90页
- 第91页
- 第92页
- 第93页
- 第94页
- 第95页
- 第96页
Lisa Park, 48, was suffering from gall bladder cancer, a rare but serious condition that usually only affects people in old age. “I was given a year to live,” said Park. It was a severe diagnosis, yet her prospect has recently taken an unexpected turn for the better.
Park was recently asked to join a revolutionary UK research programme known as Determine. It has been set up to target individuals with rare tumours(肿瘤) in the hope that drugs licensed for other disease could be appropriated as a new treatment.
“By definition, rare cancers are uncommon,” said one of the project’s leaders, oncologist(肿瘤学家) Matthew Krebs of Manchester University. “However, there are so many that in total they represent around 20% of all cancers diagnosed globally each year—more than any single type of cancer including lung and breast cancer.” Rare cancers’ total impact on the health service is therefore significant but there are few treatments currently available to help patients.
Determine has been set up to find if drugs that are already prescribed by doctors for more common types of cancer could benefit patients with rare cancers for which they have not been licensed. The study is led by Manchester University and involves several other leading medical centres in the UK. The ultimate aim is to match old drugs to new cancers. The crucial point is that scientists have discovered some very rare tumours possess abnormalities that could make them susceptible to treatments developed for common cancers. “We will be able to fast track the approval of any promising drugs, opening the door to treatments for patients who have been left with limited options,” said Iain Foulkes, director of research and innovation at Cancer Research UK.
The approach has already produced promising results for Park. “I know I still have a journey ahead of me but my cancer has been reduced to manageable tumours, and that has been a very welcome outcome,” said Park.
1. Why was Determine set up?
A. To develop new drugs for common cancers.
B. To treat people with lung and breast cancer.
C. To deal with a general cancer research further.
D. To target rare tumors and find new treatments.
2. How does the programme plan to do with rare cancers?
A. Develop completely new drugs.
B. Offer financial assistance for the research.
C. Use drugs available for common cancers.
D. Provide more professional care for patients.
3. What does the underlined phrase “susceptible” in Paragraph 4 mean?
A. Hard.
B. Sensitive.
C. Unaffected.
D. Different.
4. What’s the attitude of Park towards the treatment?
A. Optimistic.
B. Uncertain.
C. Indifferent.
D. Doubtful.
Park was recently asked to join a revolutionary UK research programme known as Determine. It has been set up to target individuals with rare tumours(肿瘤) in the hope that drugs licensed for other disease could be appropriated as a new treatment.
“By definition, rare cancers are uncommon,” said one of the project’s leaders, oncologist(肿瘤学家) Matthew Krebs of Manchester University. “However, there are so many that in total they represent around 20% of all cancers diagnosed globally each year—more than any single type of cancer including lung and breast cancer.” Rare cancers’ total impact on the health service is therefore significant but there are few treatments currently available to help patients.
Determine has been set up to find if drugs that are already prescribed by doctors for more common types of cancer could benefit patients with rare cancers for which they have not been licensed. The study is led by Manchester University and involves several other leading medical centres in the UK. The ultimate aim is to match old drugs to new cancers. The crucial point is that scientists have discovered some very rare tumours possess abnormalities that could make them susceptible to treatments developed for common cancers. “We will be able to fast track the approval of any promising drugs, opening the door to treatments for patients who have been left with limited options,” said Iain Foulkes, director of research and innovation at Cancer Research UK.
The approach has already produced promising results for Park. “I know I still have a journey ahead of me but my cancer has been reduced to manageable tumours, and that has been a very welcome outcome,” said Park.
1. Why was Determine set up?
A. To develop new drugs for common cancers.
B. To treat people with lung and breast cancer.
C. To deal with a general cancer research further.
D. To target rare tumors and find new treatments.
2. How does the programme plan to do with rare cancers?
A. Develop completely new drugs.
B. Offer financial assistance for the research.
C. Use drugs available for common cancers.
D. Provide more professional care for patients.
3. What does the underlined phrase “susceptible” in Paragraph 4 mean?
A. Hard.
B. Sensitive.
C. Unaffected.
D. Different.
4. What’s the attitude of Park towards the treatment?
A. Optimistic.
B. Uncertain.
C. Indifferent.
D. Doubtful.
答案:
1.D 2.C 3.B 4.A
查看更多完整答案,请扫码查看